These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3696269)

  • 41. [Progesterone cream--efficient in premenstrual syndrome and climacteric problems?].
    Moen MH; Buajordet M; Leirstrand T
    Tidsskr Nor Laegeforen; 2002 Jun; 122(15):1477-8. PubMed ID: 12185738
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diseases in the climacteric, with poor or without any organic findings].
    Breckwoldt M
    Z Allgemeinmed; 1975 Nov; 51(31):1415-7. PubMed ID: 128206
    [No Abstract]   [Full Text] [Related]  

  • 43. Hormone implants in the climacterium.
    Schleyer-Saunders E
    Z Alternsforsch; 1974; 28(3):205-10. PubMed ID: 4156986
    [No Abstract]   [Full Text] [Related]  

  • 44. Transdermal estradiol.
    Basdevant A; Conard J; Guy-Grand B
    N Engl J Med; 1986 Dec; 315(24):1550-1. PubMed ID: 3785313
    [No Abstract]   [Full Text] [Related]  

  • 45. [No increase in the incidence of breast carcinoma with subcutaneous administration of estradiol].
    Ned Tijdschr Geneeskd; 1991 Jun; 135(25):1145-6. PubMed ID: 1857444
    [No Abstract]   [Full Text] [Related]  

  • 46. Transdermal dosage forms.
    Shaw JE
    Methods Enzymol; 1985; 112():448-61. PubMed ID: 3930919
    [No Abstract]   [Full Text] [Related]  

  • 47. The climateric syndrome in Nigeria.
    Okpere EE; Faal MK; Omu A
    East Afr Med J; 1988 Apr; 65(4):283-7. PubMed ID: 3168862
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pro and contra hormonal substitution in the climacteric].
    Vesper B
    Gynakol Rundsch; 1988; 28 Suppl 2():175-8. PubMed ID: 3234914
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical experience of clonidine in treatment of menopausal flushing.
    Jacobsen L
    Acta Obstet Gynecol Scand Suppl; 1985; 132():35. PubMed ID: 3861065
    [No Abstract]   [Full Text] [Related]  

  • 50. Dixarit and flushing.
    Blunt R
    Med J Aust; 1979 Aug; 2(4):199-200. PubMed ID: 514134
    [No Abstract]   [Full Text] [Related]  

  • 51. Climacteric flushing in a man.
    Ginsburg J; O'Reilly B
    Br Med J (Clin Res Ed); 1983 Jul; 287(6387):262. PubMed ID: 6409274
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comment on Edith Szanto, Doris Gruber, M. Sator, W. Knogler and J. C. Huber: Placebo controlled study of Melbrosia in treatment of climacteric symptoms].
    Sieder C
    Wien Med Wochenschr; 1995; 145(1):17. PubMed ID: 7771100
    [No Abstract]   [Full Text] [Related]  

  • 53. Tachyphylaxis and oestradiol implants.
    Evans D
    Med J Aust; 1994 Sep; 161(5):344. PubMed ID: 7830683
    [No Abstract]   [Full Text] [Related]  

  • 54. Flushes, neurodermatology, and surroundings.
    Capella GL
    J Am Acad Dermatol; 2018 May; 78(5):e123. PubMed ID: 29678384
    [No Abstract]   [Full Text] [Related]  

  • 55. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
    van Leusden HA
    Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
    [No Abstract]   [Full Text] [Related]  

  • 57. [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].
    Schenkel L; von Graffenried A
    Schweiz Rundsch Med Prax; 1987 Mar; 76(14):358-61. PubMed ID: 3589291
    [No Abstract]   [Full Text] [Related]  

  • 58. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 59. [A transdermal therapeutic estradiol system for physiological hormone substitution in the menopause].
    Schenkel L
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):277-82. PubMed ID: 3887536
    [No Abstract]   [Full Text] [Related]  

  • 60. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.